David Perry

David P.
Perry is the founder.
He founded Ventro Corp.
in 1997 and served as the Chief Executive Officer in 2001.
He also founded Anacor Pharmaceuticals LLC in 2002 and held the positions of President, Chief Executive Officer & Director until 2014.
In 2015, Mr. Perry founded Better Therapeutics, Inc. and served as the Executive Chairman.
Mr. Perry is also the founder of Better Therapeutics LLC.
Currently, Mr. Perry holds the position of Director at the Infectious Disease Research Institute and Director at the A.P.
Giannini Foundation.
Mr. Perry's former positions include being the President, Chief Executive Officer & Director at Indigo Ag, Inc. from 2015 to 2020, Vice Chairman at NexPrise, Inc., Independent Director at Evelo Biosciences, Inc. from 2016 to 2022, Manager at Exxon Corp., and Principal at Small Business Development Group, Inc. In terms of education, Mr. Perry completed his undergraduate degree at The University of Tulsa and obtained an MBA from Harvard Business School.